The blood biomarker phosphorylated tau 217 (p-tau217) may predict dementia in women up to 25 years before onset, according to a study published in JAMA Network Open.
JAMA (Journal of the American Medical Association) published a clinical update in Research Highlights on 21 Apr 2026.
The item focuses on Biomarker P-Tau217 May Help Predict Long-Term Dementia Risk.
Review the original article for the full source wording and details.